Vasorin, an antagonist of TGF-β is decreased in glaucoma patients
Publication
, Conference
Choi, JA; Karnam, S; Skiba, N; Maddala, R; Challa, P; Vann, R; Rao, V
Published in: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
2021
Duke Scholars
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
EISSN
1552-5783
ISSN
0146-0404
Publication Date
2021
Volume
62
Issue
8
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Choi, J. A., Karnam, S., Skiba, N., Maddala, R., Challa, P., Vann, R., & Rao, V. (2021). Vasorin, an antagonist of TGF-β is decreased in glaucoma patients. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 62).
Choi, Jin A., Shruthi Karnam, Nikolai Skiba, Rupalatha Maddala, Pratap Challa, Robin Vann, and Vasantha Rao. “Vasorin, an antagonist of TGF-β is decreased in glaucoma patients.” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, Vol. 62, 2021.
Choi JA, Karnam S, Skiba N, Maddala R, Challa P, Vann R, et al. Vasorin, an antagonist of TGF-β is decreased in glaucoma patients. In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2021.
Choi, Jin A., et al. “Vasorin, an antagonist of TGF-β is decreased in glaucoma patients.” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 62, no. 8, 2021.
Choi JA, Karnam S, Skiba N, Maddala R, Challa P, Vann R, Rao V. Vasorin, an antagonist of TGF-β is decreased in glaucoma patients. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2021.
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
EISSN
1552-5783
ISSN
0146-0404
Publication Date
2021
Volume
62
Issue
8
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 11 Medical and Health Sciences
- 06 Biological Sciences